Collectively, our data suggest that TPM3P9 upregulates RELB expression to trigger NF-κB signaling via the TCF7L2-L/SAM68 complex in ccRCC cells. The gene discussed is TPM3P9; the disease is nonpapillary renal cell carcinoma.